Accueil / Tag Archives: Stem Cells (page 119)

Tag Archives: Stem Cells

Illumina Expands Use of HiSeq X™ Sequencing System to Include Non-Human Species

Tuesday, October 6th 2015 at 10:30am UTC SAN DIEGO–(BUSINESS WIRE)– Illumina, Inc. (NASDAQ:ILMN) today announced it has expanded the rights of use for the HiSeq X Sequencing System to allow customers to perform whole-genome sequencing of non-human species. The updated rights of use will take effect immediately for existing customers of …

Plus »

Genzyme Introduces “vs.MS,” a Global Initiative Aimed at Uncovering the Often Unspoken Challenges of MS to Drive Better Informed Care

Monday, October 5th 2015 at 1:00pm UTC – Initial Findings from Global Survey of People Living with Relapsing Multiple Sclerosis (RMS) and Care Partners to be Shared at ECTRIMS – CAMBRIDGE, Mass.–(BUSINESS WIRE)– Genzyme, a Sanofi company, today announced a new global initiative, vs.MS, that is designed to raise awareness …

Plus »

InVivo Therapeutics to Present at the 2015 Aegis Growth Conference

Monday, October 5th 2015 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– InVivo Therapeutics Holdings Corp. (NVIV) today announced that Mark Perrin, Chief Executive Officer and Chairman, is scheduled to present at the 2015 Aegis Growth Conference to be held October 7-9, 2015 in Las Vegas, Nevada. The company’s presentation will be on …

Plus »

Osiris Therapeutics to Present at the 2015 Stem Cell Meeting on the Mesa

Friday, October 2nd 2015 at 12:00pm UTC COLUMBIA, Md.–(BUSINESS WIRE)– Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine markets, announced today that Lode Debrabandere, Ph.D., President and Chief Executive Officer, is …

Plus »

BioTime Announces the Closing of a $20 Million Direct Registered Offering; Demand Exceeds NIS 80 Million Offered

Thursday, October 1st 2015 at 7:17pm UTC – Offering Priced at $3.13 Per Share– Inclusion in Six Major Indexes of the Tel Aviv Stock Exchange ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE MKT and TASE: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today announced …

Plus »

SERMO Partners with Global Genes to Battle Rare Diseases

Wednesday, September 30th 2015 at 6:49pm UTC New SERMOheroes Program Helps Patients with Rare Diseases Benefit from Medical Crowdsourcing NEW YORK–(BUSINESS WIRE)– SERMO, the leading global social network for physicians, and Global Genes™, a leading rare disease patient advocacy organization, announced at the 4th annual Rare Patient Advocacy Summit this weekend …

Plus »

AntiCancer Inc. Announces New Technology for Growing Hair in Long-Term Culture

Wednesday, September 30th 2015 at 7:53pm UTC SAN DIEGO–(BUSINESS WIRE)– AntiCancer Inc. has announced extensive hair-shaft elongation by isolated mouse whisker follicles in very long-term culture outside the body. AntiCancer Inc. has previously discovered that cultured skin can produce growing hair. In their new study, AntiCancer scientists have grown hair …

Plus »

Heraeus Medical GmbH and BioTime Subsidiary OrthoCyte Corporation Enter Into Exclusive Worldwide Development and Licensing Agreements

Wednesday, September 30th 2015 at 8:00am UTC Agreements Provide for the Development of an Innovative Cell Therapy Product for Bone Grafting in Orthopedic Unmet Needs Heraeus Medical to Fund All Product Development and Commercial Sales and Marketing Efforts OrthoCyte Will Be Responsible for Product Development and Manufacturing HANAU, Germany & …

Plus »

Solving Organ Shortage Announces Strategic Research Goals to Regenerate or Bioengineer a Kidney

Tuesday, September 29th 2015 at 2:07pm UTC AUSTIN, Texas–(BUSINESS WIRE)– Solving Organ Shortage today announced the Phase One Strategic Research Goals identified by its Whole Kidney Research Community, a multidisciplinary group of senior academic investigators collaborating to develop techniques and technologies to regenerate failing kidneys or engineer replacement organs for …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.